First Eagle Investment Management, LLC - THRESHOLD PHARMACEUTICAL INC ownership

THRESHOLD PHARMACEUTICAL INC's ticker is THLD and the CUSIP is 885807206. A total of 36 filers reported holding THRESHOLD PHARMACEUTICAL INC in Q2 2017. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
First Eagle Investment Management, LLC ownership history of THRESHOLD PHARMACEUTICAL INC
ValueSharesWeighting
Q2 2017$2,788,000
-31.0%
7,093,8020.0%0.01%
-30.0%
Q1 2017$4,043,000
+29.3%
7,093,8020.0%0.01%
+25.0%
Q4 2016$3,128,000
-22.7%
7,093,802
+18.7%
0.01%
-20.0%
Q3 2016$4,048,000
+99.1%
5,974,802
+86.7%
0.01%
+100.0%
Q2 2016$2,033,000
-0.1%
3,199,433
+539.9%
0.01%0.0%
Q3 2015$2,035,000
-60.4%
500,000
-60.7%
0.01%
-58.3%
Q2 2015$5,134,000
-10.0%
1,270,768
-9.6%
0.01%
-14.3%
Q1 2015$5,707,000
+30.3%
1,405,768
+2.1%
0.01%
+27.3%
Q4 2014$4,380,000
+11.1%
1,377,448
+26.2%
0.01%
+10.0%
Q3 2014$3,941,000
+24.4%
1,091,700
+36.5%
0.01%
+25.0%
Q2 2014$3,168,000
-4.9%
800,000
+14.3%
0.01%
-11.1%
Q1 2014$3,332,000
+256.7%
700,000
+250.0%
0.01%
+200.0%
Q4 2013$934,000
+0.4%
200,0000.0%0.00%0.0%
Q3 2013$930,000
-11.6%
200,0000.0%0.00%0.0%
Q2 2013$1,052,000200,0000.00%
Other shareholders
THRESHOLD PHARMACEUTICAL INC shareholders Q2 2017
NameSharesValueWeighting ↓
DAFNA Capital Management LLC 625,558$2,540,0001.95%
CG Asset Management LLC 128,000$520,0000.20%
Rotella Capital Management, Inc. 45,364$184,0000.15%
TFS CAPITAL LLC 348,617$1,415,0000.14%
Rhenman & Partners Asset Management AB 201,537$818,0000.14%
FORTALEZA ASSET MANAGEMENT INC/ 59,180$240,0000.14%
Baker Brothers Advisors 2,925,519$11,878,0000.10%
FEDERATED HERMES, INC. 3,918,305$15,908,0000.05%
FRANKLIN STREET ADVISORS INC /NC 50,000$203,0000.04%
Princeton Alpha Management LP 26,560$108,0000.02%
View complete list of THRESHOLD PHARMACEUTICAL INC shareholders